Cure My Disease

Don't miss your cure!

 Log in / Sign up

New stem cell transplant trial offers hope for blood cancer patients

NCT ID NCT04195633

Recruiting now Disease control Sponsor: Fred Hutchinson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a stem cell transplant from half-matched (haploidentical) donors for people with various blood cancers. Before the transplant, patients receive chemotherapy and low-dose radiation to prepare their body. The goal is to replace diseased bone marrow with healthy donor cells that can fight the cancer. This is a Phase 2 trial with 60 participants, focusing on controlling the disease rather than providing a cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute biphenotypic leukemia acute leukemia acute lymphoblastic leukemia acute myeloid leukemia anaplastic large cell lymphoma B-cell chronic lymphocytic leukemia Burkitt lymphoma chronic myelogenous leukemia, BCR-ABL1 positive chronic myelomonocytic leukemia diffuse large B-cell lymphoma follicular lymphoma Hodgkins lymphoma Leukemia, Myelogenous, Chronic, BCR-ABL Positive lymphoblastic lymphoma Lymphoma, B-Cell, Marginal Zone lymphoplasmacytic lymphoma mantle cell lymphoma mixed phenotype acute leukemia myelodysplastic syndrome Myelodysplastic Syndromes Precursor Cell Lymphoblastic Leukemia-Lymphoma prolymphocytic leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE LEUKEMIA ACUTE LYMPHOBLASTIC LEUKEMIA ACUTE MYELOID LEUKEMIA ADULT DIFFUSE LARGE CELL LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA BURKITT LYMPHOMA CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE CHRONIC MYELOMONOCYTIC LEUKEMIA HODGKIN LYMPHOMA LYMPHOBLASTIC LYMPHOMA LYMPHOPLASMACYTIC LYMPHOMA MANTLE CELL LYMPHOMA MIXED PHENOTYPE ACUTE LEUKEMIA MYELODYSPLASTIC SYNDROME PROLYMPHOCYTIC LEUKEMIA REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA REFRACTORY FOLLICULAR LYMPHOMA REFRACTORY MARGINAL ZONE LYMPHOMA REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    RECRUITING

    Seattle, Washington, 98109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact